10 September 2019:
CNBP has officially welcomed UNSW, one of the world’s leaders at translational engineering research, as its newest node.
In addition to the official open by UNSW Engineering Dean Professor Mark Hoffman, CNPB Director Professor Mark Hutchinson took the opportunity to lay out the CNBP mission and its accomplishments at an industry showcase. Continue reading
CNBP PhD Student Ms Yuan Qi Yeoh enjoyed a two week collaborative visit with Prof Xuefeng Guo’s team at Peking University. Working with Peking University PhD student Xinjiani Chen on a research project involving the molecular dynamics of the secondary structure of a cyclic photoswitchable peptide.
Yuan Qi had the opportunity to participate in the fabrication process of the single-molecule devices. Specifically, they carried out temperature-dependent experiments using their advanced facilities to probe the molecular dynamics of the secondary structure upon photoswitching.
Yuan Qi says that “It was a great opportunity to collaborate with colleagues at Peking University in such high impact research and enjoyed working in their sophisticated research labs”
15 August 2017:
The University of Colorado Boulder (CU) and the Centre for Nanoscale BioPhotonics (CNBP) have officially announced their research partnership status at a launch event that took place at CU today.
The collaboration between the CNBP, an Australian Research Council Centre of Excellence, and the University of Colorado Boulder, will explore the use of novel CNBP biophotonics tools and techniques to examine in real-time, neuroinflammatory processes that govern behavior.
The novel immune sensing technologies developed at CNBP will allow circuit-specific measurement of immune molecule release during stress-related paradigms in rodents performed at the University of Colorado Boulder.
The overarching goal of the collaboration is to better inform intervention efforts
focused on stress- and ageing-related diseases.
Partner Investigators at CU are Professor Steven Maier and Professor Linda Watkins with CU’s Dr Michael Baratta (the successful recipient of the CNBP-American Australian Association Fellowship in 2016), also working closely with this partnership.
Below: CNBP Director Prof Mark Hutchinson (left) presents a partner plaque to Partner Investigators – Professor Steven Maier and Professor Linda Watkins.
16 May 2017:
On a recent trip to China, CNBP Research Fellow A/Prof Guozhen Liu undertook a number of visits and talks, discussing her advanced sensing, nano-particle and bio-imaging work. This included:
5 May-8 May: Attendance at the International Congress on Analytical Sciences 2017 (ICAS2017) at Kaikou, China. Here Guozhen gave an oral presentation with the title “Engineering reduced graphen oxides towards a label-free electrochemical immunosensor for detection of tumor necrosis factor-alpha.”
11 May: Guozhen gave an invited talk titled, “Nanotools for cytokine monitoring in neuroscience” at Prof Zhihong Zhang’s research team at Huazhong University of Science and Technology, Wuhan. Prof Zhang is one of CNBP’s Partner Investigators at HUST.
13-14 May: Guozhen provided a keynote speech, titled, “An optical fibre based ex-vivo device for detection of cytokines” at the 2nd International Congress on Biomedical Imaging and Signal Processing (ICBISP 2017) at Wuhan.
Below: A/Prof Guozhen Liu (right) visiting CNBP Partner Investigator Prof Zhihong Zhang.
23 November 2016:
Centre personnel, laboratories and microscopes were on display at Macquarie University, Wednesday November 23rd, as guests from industry partner Olympus Australia took time out of their busy schedules to visit and to explore the latest in imaging developments taking place at the CNBP.
Hosted by CNBP node leader Prof Jim Piper and CNBP Associate Investigator Dr Yiqing Lu, Olympus Australia’s Kim Everuss (Sales Manager, MIS), Jian Shen (Marketing Manager, MIS), Chunsong Yan (Customer Experience Service Manager) and Clare Kelly (Product Manager specialising in confocal microscopy) were shown the latest in CNBP research, spoke with CNBP researchers and actively inspected tools and techniques related to the Centre’s luminescence related microscopy activity. Of particular focus was Centre work on a ‘plug and play’ time-gated imaging module that could be easily linked to current Olympus microscope setups.
Presentations from CNBP researchers also took place during the visit, outlining biological applications including biomedical diagnostics and drug delivery and leading edge research in the biology of pain.
Prof Jim Piper noted that the visit further cemented the fantastic relationship between the two organisations and that he looked forward to working closely with Olympus Australia with a view to facilitating industry-research benefits for both parties.
Below – CNBP Associate Investigator Dr Yiqing Lu explains the technology involved in the innovative time-gated imaging module.
26 August 2016:
Olympus LIVE hosted a workshop today, involving a group of Quantum Physics researchers and students from RMIT University and the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP).
It was the first microscopy workshop of its kind involving Olympus, the University and Centre, giving students valuable exposure and hands-on experience with resident Olympus microscopy experts.
The initial planning for the event was coordinated by CNBP Chief Investigator Prof Andrew Greentree from RMIT University (pictured top left) and CNBP industry partner Mr Jian Shen from Olympus Australia. The day consisted of a training/education session that was part of the ‘Masters in Nanotechnology and Smart Materials’ course, which is in its first year at RMIT University.
The event was hosted by Olympus at their state of the art new facility at Notting Hill, Melbourne and included a theory session, hands on training on microscopes run by Olympus experts, and a tour of some of the facilities.
It is planned that this will become an annual event as part of the ‘Masters in Nanotechnology and Smart Materials’ course at RMIT.
Said Prof Greentree, “This is just another way that the Olympus/CNBP partnership is providing benefits above and beyond that of direct research.”
25 August 2016:
CNBP and the Leibniz Institute of Photonic Technology (IPHT) in Jena officially acknowledged their long term research and collaboration activity with a formal partnership launch today, taking place at IPHT HQ in Germany.
CNBP Deputy Director Prof Ewa Goldys, CNBP Macquarie University Node Leader Prof Jim Piper and CNBP RMIT University Node Leader A/Prof Brant Gibson were all in attendance at the event which was hosted and led by Partner, Prof Jurgen Popp from IPHT. CNBP’s Associate Investigator, Dr Stephen Warren-Smith who is just concluding his Marie Curie Fellowship with IPHT, and will be returning to the University of Adelaide after securing a Ramsay Fellowship, was also present and attended the program of the 3 day partner launch.
Included as a part of launch activity were presentations from both organisations, tours of IPHT laboratory space, research updates on key projects and engagement with CNBP industry partner Heraeus.
Specific highlights from the visit included the opening of the partner launch at the Scala Tower Restaurant in Jena with CNBP’s Prof Jim Piper presenting a keynote presentation, a tour of the InfectoGnostic Research Campus and a visit to Zeiss, concluding with a lecture from Prof Ewa Goldys.
Pictured top left is IPHT Partner, Prof Jurgen Popp being presented with the CNBP Partner Plaque by CNBP Deputy Director Prof Ewa Goldys.
30 May 2016:
The CNBP has officially launched an international research partnership with the University Health Network (Toronto) following a successful event, undertaken at the Princess Margaret Cancer Centre on the 30th May 2016.
The partnership broadens the potential for research collaboration between the CNBP and the UHN as well as strengthens the current links and ties that already exist between the two organisations.
According to CNBP Director, Prof Mark Hutchinson, highlights from the day included an all day science workshop featuring plenty of opportunities for brainstorming between the teams researchers, as well as the identification of immediate opportunities for materials and sample sharing.
“Formalizing the partnership between the CNBP and the UHN makes perfect sense and will provide both organisations with improved opportunities and expertise in the undertaking of leading edge biophotonics research”, said Hutchinson.
Below, the formal handover of the CNBP partner plaque by CNBP Director Prof Mark Hutchinson (far right) to UHN’s Prof Brian Wilson (second right).
24 November 2015:
A new collaboration agreement has been announced today by Macquarie University and clinical-stage regenerative medicine company Regeneus Ltd, to commercialise a breakthrough cell selection technology that for the first time allows high potency secreting stem cells to be identified and selected for the manufacture of next generation cell therapies.
The technology was developed in a research group led by Professor Ewa Goldys and Dr Guozhen Liu at the Australian Research Council’s Centre of Excellence for Nanoscale BioPhotonics (CNBP) at Macquarie, and uses innovative cell labelling technologies to identify and select cells based on the molecules that they are secreting rather than their surface characteristics used currently.
Read more here:
9 November 2015:
CNBP successfully launched its partnership with Bioplatforms Australia at a larger Node event at Macquarie University, Sydney, Nov 9th, 2015.
The partner launch, added to the official proceedings of the CNBP Macquarie University research node launch, featured CNBP Director Prof Mark Hutchinson and General Manager for Bioplatforms Australia, Mr Andrew Gilbert.
Mark Hutchinson noted the importance of the partnership with Bioplatforms Australia, with the organisation enabling CNBP research, with its world-class platform technologies and associated expertise in the specialist fields of genomics, proteomics, metabolomics and bioinformatics.
Prof Hutchinson then presented Mr Gilbert with a CNBP partner plaque and noted that he was looking forward to ongoing collaborations, particularly in the areas of biomedical research. Mr Gilbert concurred, with both individuals then posing for official launch photos.